CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Contraception - Management
How does venous thromboembolism (current and risk factors for) influence choice?
- Women with known thrombogenic mutations, history of venous thromboembolism, or taking anticoagulants for current venous thromboembolism
- Methods that can be used without restriction: copper intrauterine devices (IUDs), barrier methods, and natural family planning.
- Methods that can generally be used (advantages generally outweigh the risks): progestogen-only pill, progestogen-only implants and injectables, and the levonorgestrel-releasing intrauterine system (IUS).
- Methods that should not be used (because of unacceptable risk): combined oral contraceptives (COCs), the combined contraceptive patch, and combined contraceptive vaginal ring.
Clarification / Additional information
Basis for recommendation
- These recommendations are based on guidelines published by the Faculty of Sexual and Reproductive Health Care (FSRHC), formerly the Faculty of Family Planning and Reproductive Health Care (FFPRHC) [FSRH, 2009b].
© NHS Institute for Innovation and Improvement